Volume 14, Issue 3 (May-Jun 2020)                   mljgoums 2020, 14(3): 33-39 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Abdullahi I N, Adekola H A, Emeribe A U, Ahmad A E, Yunusa T, Zakari M M, et al . Association of Hemoglobin Electrophoretic Phenotype with Human Parvovirus B19 infection among Pregnant Women attending Abuja Tertiary Hospital, Nigeria. mljgoums. 2020; 14 (3) :33-39
URL: http://mlj.goums.ac.ir/article-1-1290-en.html
1- Department of Medical Laboratory Science, Ahmadu Bello University Zaria Nigeria , eedris888@yahoo.com
2- Department of Microbiology, Olabisi Onabanjo University, Ogun state, Nigeria
3- Department of Medical Laboratory Science, University of Calabar, Calabar, Nigeria
4- Department of Medical Laboratory Science, Ahmadu Bello University Zaria Nigeria
5- Department of Medical Microbiology and Parasitology, University of Abuja, Abuja, Nigeria
6- Department of Obstetrics and Gyaenacology, University of Abuja Teaching Hospital, Gwagwalada, Abuja, Nigeria
7- Department of Strategic Information and Research, Institute of Human Virology, Abuja, Nigeria
8- Department of Medical Microbiology and Parasitology, University of Ilorin Teaching Hospital, Ilorin, Nigeria
9- Department of Medical Laboratory Science, University of Maiduguri, Maiduguri, Nigeria
Abstract:   (916 Views)
Background and Objectives: Human parvovirus B19 (B19V) is a widespread virus with various manifestations depending on the immunologic and hematologic status of the host. Infection with the virus can cause a wide range of complications in fetus of infected pregnant women, especially those with hemoglobinopathies. This study aimed to determine association of hemoglobin electrophoretic patterns and risk of B19V infection in pregnant women.
 
      Methods: Blood samples were collected from 200 pregnant women attending University of Abuja Teaching Hospital, Abuja, Nigeria. The samples were screened for anti-B19V IgM and IgG. Hemoglobin patterns were determined using commercial enzyme-linked immunosorbent assay kits and Minicap Flex Piercing Electrophoresis system. Structured questionnaires were used to collate sociodemographic variables and associated risk factors of B19V.
 
      Results: Of 200 participants, 12 (6.0%) were positive for B19V IgM, 45 (22.5%) were positive for IgG and two (1.0%) were positive for both antibody, while 145 (72.5%) had no detectable B19V antibody. Twenty-six subjects (28.3%) with HbAA hemoglobin pattern had B19V IgG of whom, nine (12.5%) had HbAS and 11 (30.6%) had HbSS electrophoretic patterns. There was a significant association between prevalence of anti-B19V IgG and hemoglobin electrophoretic pattern of participants (P=0.037). However, no association was found between prevalence of B19V IgM and hemoglobin electrophoretic pattern, age and parity of pregnant women (P>0.05).
 
      Conclusion: Our findings revealed a high prevalence of B19V infection among pregnant women in the studied area. In addition, acute B19V seems to be associated with hemoglobin electrophoretic patterns of pregnant women. It is recommended to follow up newborns of anti-B19V IgM positive pregnant women.
Full-Text [PDF 522 kb]   (141 Downloads)    
Type of Study: Original Paper | Subject: Virology
Received: 2020/04/17 | Accepted: 2020/04/30 | Published: 2020/04/30 | ePublished: 2020/04/30

References
1. Luo Y, Qiu J. Human parvovirus B19: a mechanistic overview of infection and DNA replication. Future Virol 2015; 10:155-67. [DOI:10.2217/fvl.14.103]
2. Ganaie S, Qiu J. Recent Advances in Replication and Infection of Human Parvovirus. Front Cell Infect Microbiol 2018; 8:166. [DOI:10.3389/fcimb.2018.00166]
3. Naciute M, Meiliauskaite D, Rugirnr R, Nikitenkiene R, Jancoriene L, Mauricas M, et al. Frequency and significance of parvovirus B19 infection in patients with rheumatoid arthritis. J Gen Virol 2016; 97:3302-12. [DOI:10.1099/jgv.0.000621]
4. Jegede A, Aminu A, Ella E. Seroprevalence of human parvovirus B19 among patients attending some hospitals in Kano metropolis, Nigeria. Afr J Clin Exper Micro 2014; 15: 21-6. [DOI:10.4314/ajcem.v15i1.4]
5. Crane J, Mundle W, Boucoiran, I. Parvovirus B19 Infection in Pregnancy. J Obstet Gynaecol Can 2014; 36 : 1107-16. [DOI:10.1016/S1701-2163(15)30390-X]
6. Lamont R, Sobel J, Vaisbuch E, Kusanovic J, Mazaki-Tovi S, Kim S, et al. Parvovirus B19 Infection in Human pregnancy. BJOG 2011; 118: 175-86. [DOI:10.1111/j.1471-0528.2010.02749.x]
7. Habibzadeh S, Peeri-Doghagheh H, Mohammad-Shahi J, Mobini E, Shahbazzadegan S. The prevalence of parvovirus B19 infection among pregnant women of Ardabil in 2013. Iran J Microbiol 2016; 8: 214-8.
8. Chirambo-Kalolekesha M, Kaile T, Mwaba F, Daka V, Simakando M, Kowa S. Seroprevalence of parvovirus B19 in blood donors: the risks and challenges of blood transfusion in Zambia in the era of HIV/AIDS at the Kitwe Central Hospital, blood bank. Afr Health Sci 2018; 18:496-502. [DOI:10.4314/ahs.v18i3.5]
9. Mirambo M, Maliki F, Majigo M, Mushi M, Moremi N, Seni J, et al. The magnitude and correlates of Parvovirus B19 infection among pregnant women attending antenatal clinics in Mwanza, Tanzania. BMC Pregnancy Childbirth 2017; 17: 17 [DOI:10.1186/s12884-017-1364-y]
10. Giorgio E, De Oronzo M, Iozza I, Di Natale A, Cianci S, Garofalo G, et al. Parvovirus B19 during pregnancy: a review. J Prenat Med 2010; 4: 63-6.
11. Abiodun I, Opaleye O, Ojurongbe O, Fagbami A. Seroprevalence of parvovirus B19 IgG and IgM antibodies among pregnant women in Oyo State, Nigeria. J Infect Dev Ctries 2013; 7: 946-50. [DOI:10.3855/jidc.3157]
12. Heegaard E, Petersen B, Heilmann C, Hornsleth A. Prevalence of Parvovirus B19 and Parvovirus V9 DNA antibodies in Paired Bone Marrow and Serum Samples from Healthy Individuals. J Clin Microbiol 2002; 40: 933-6. [DOI:10.1128/JCM.40.3.933-936.2002]
13. Slavov S, Kashima S, Pinto A, Covas D. Human Parvovirus B19: general considerations and impact on patients with sickle-cell disease and thalassemia and on blood transfusions. FEMS Immunol Med Microbiol 2011; 62: 247-62. [DOI:10.1111/j.1574-695X.2011.00819.x]
14. Toyokawa Y, Kingetsu I, Yasuda C, Yasuda J, Yoshida K, Kurosaka D, et al. Case of pure red aplasia complicated by Evans syndrome. Mod Rheumatol 2007; 17: 333-7. [DOI:10.3109/s10165-007-0584-9]
15. Win N, Lee E, Needs M, Homeida S, Stasi R. Profound sustained reticulocytopenia and anaemia in an adult patient with sickle cell disease. Transf Med 2014; 24: 418-20. [DOI:10.1111/tme.12168]
16. Smith-Whitley K, Zhao H, Hodinka R, Kwiatkowski J, Cecil R, Cecil T, et al. Epidemiology of Human parvovirus B19 in children with sickle cell disease. Blood Vol 2004; 103: 422-7. [DOI:10.1182/blood-2003-01-0069]
17. Adewoyin A, Busari O, Aworanti O. Hemoglobin Phenotypes in Nigeria: Data from a National Reference Laboratory. Am J Clin Pathol 2019; 152(1): S115-S116, [DOI:10.1093/ajcp/aqz121.027]
18. Keikha F, Miri-Moghaddam E, Sharifi-Mood B. Prevalence of parvovirus B19 infection in successful and unsuccessful pregnancy in Zahedan, southeast of Iran J Med Sci 2006; 6: 495-7 [DOI:10.3923/jms.2006.495.497]
19. Elnifro E, Nisha AK, Almabsoot M, Daeki A, Mujber N, Muscat J. Seroprevalence of parvovirus B19 among pregnant women in Tripoli, Libya. J Infect Dev Ctries 2009; 3:218- 20 [DOI:10.3855/jidc.38]
20. Akyala I, Amuta E, Azua A, Agieni A. Parvovirus B19: Evaluation of Incidence, Prevalence and Risk Factors among Pregnant Women Attending Ante-Natal Clinic in Nassarawa stae, North Central of Nigeria. Clin Med Diag 2012; 2: 54-9. [DOI:10.5923/j.cmd.20120205.03]
21. Emiasegen S, Nimzing L, Adoga M, Ohagenyi A, Lekan R. Parvovirus B19 antibodies and correlates of infection in pregnant women attending an antenatal clinic in central Nigeria. Mem Inst Oswaldo Cruz 2011; 106:227-31. [DOI:10.1590/S0074-02762011000200018]
22. Ayolabi C, Onwuzo S, Ejere J, Ibemgbo S, Solanke T. Detection of parvovirus B19 IgM in patients with sickle cell disease in Lagos, Nigeria. Asian Pac J Trop Dis 2017; 7: 430-2. [DOI:10.12980/apjtd.7.2017D7-14]
23. Koch WC and Adler SP. Human parvovirus infection in pregnancy. Pediatr Infect Dis J 1989; 8:83-7
24. Makshed M, Pacsa A, Essa S, Ahmed M, Monem R, Surkouh M. The prevalence of antibody to human parvovirus B19 in pregnant women in Kuwait. Acta Tropica 1999; 73: 225-9. [DOI:10.1016/S0001-706X(99)00033-9]
25. Jensen I, Thorsen P, Jeune BR. Vestergaard: An epidemic of parvovirus B19 in a population of 3596 pregnant Woman: a study of sociodemographic and medical risk factors. BJOG 2000;107:637-43 [DOI:10.1111/j.1471-0528.2000.tb13306.x]
26. Iwalokun BA, Iwalokun SO, Hodonu SO. Seroprevalence of parvovirus B19 antibodies and evidence of viremia among Nigerian patients with sickle cell anemia. J Biomed Res. 2013 27:272-82.
27. Saad AA, Beshlawi I, Al-Rawas AH, Zachariah M, Nazir HF, Wali Y. Human Parvovirus B19 in Children with Sickle Cell Disease; Poking the Spleen. Oman Med J. 2017; 32: 425-8. [DOI:10.5001/omj.2017.79]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


© 2007 All Rights Reserved | Medical Laboratory Journal